Ligand validation:6W83

D12: DODECANE

D12 is a Ligand Of Interest in 6W83 designated by the RCSB

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6W83_D12_A_403	65%	70%	0.146	0.947	0.33	0.81	-	-	0	0	100%	1
6W83_D12_A_404	12%	69%	0.281	0.815	0.33	0.84	-	-	0	0	100%	1
6W84_D12_A_404	75%	70%	0.118	0.951	0.29	0.85	-	-	0	0	100%	1
6W82_D12_A_404	65%	70%	0.139	0.94	0.36	0.8	-	-	0	0	100%	1
6W86_D12_A_410	59%	82%	0.135	0.915	0.46	0.35	-	-	0	0	100%	1
6W7B_D12_A_402	51%	61%	0.174	0.928	0.49	1	-	-	0	0	100%	1
6W88_D12_B_405	46%	71%	0.159	0.894	0.3	0.82	-	-	0	0	100%	1
3UTY_D12_A_501	99%	67%	0.058	0.988	0.22	1.03	-	1	0	0	100%	1
3UTX_D12_B_401	94%	12%	0.076	0.977	1.73	2.32	2	5	0	0	100%	1
4Y9H_D12_A_305	70%	83%	0.094	0.909	0.26	0.52	-	-	0	0	100%	1
3HAS_D12_A_401	69%	0%	0.096	0.91	3.48	6.45	6	5	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.